Recipe for perfect balance of breaks and repairs in our genome could help fight cancer

June 12, 2018, University of Sheffield
Credit: CC0 Public Domain

Scientists at the University of Sheffield have discovered what keeps the perfect balance of breaks and repairs in our DNA—something which could help improve the success of chemotherapy and combat neurodegeneration associated with ageing.

Our genome, where precious genetic information is stored, is challenged with thousands of breaks every day.

Cells possess an army of proteins that search for, detect and fix these breaks to maintain genome integrity, but little is known about how the cell fine-tunes the level of response in these factories to suit each and every repair event.

The level of proteins in our is controlled by synthesis and degradation. Cells get rid of proteins when not needed by attaching a small peptide called ubiquitin.

The new study, led by Dr. Sherif El-Khamisy at the University of Sheffield's Department of Molecular Biology and Biotechnology, has revealed an enzyme called UCHL3, which controls DNA repair by removing ubiquitin marks from TDP1—a DNA repair protein. The findings also have implications in brain ageing which has an affect on memory, cognitive function and learning.

An overexpression of UCHL3 causes less ubiquitination of TDP1 and increases its level, which is found in chemotherapy resistant cancers such as rhabdosarcoma—the most common in children, which has a debilitating effect on the muscles, tendons and cartilage.

Too little UCHL3, however, was found to cause more ubiquitination of TDP1 reducing its level in such as ataxias—a group of disorders that affect co-ordination, balance and speech.

Dr. El-Khamisy said: "This study identifies UCHL3 as a novel therapeutically druggable target where suppression of its activity can improve cancer treatment, whereas encouraging and fuelling its activity can combat neurodegeneration.

"Defective DNA repair is a common theme in a number of neurological disorders including and dementia. Finding novel approaches to fuel the cell's ability to repair genomic breaks may hold promise in improving treatment of a broad range of neurological diseases."

The five-year study is funded by a Wellcome Trust Investigator Award to Dr. El-Khamisy and involved collaborations across departments at The University of Sheffield and internationally.

The full study is published today (12 June 2018) in the journal Cell Reports.

Explore further: Enzyme that regulates DNA repair may offer new precision treatments for breast and ovarian cancer

Related Stories

Enzyme that regulates DNA repair may offer new precision treatments for breast and ovarian cancer

December 12, 2016
Researchers at Mayo Clinic have identified an enzyme called UCHL3 that regulates the BRCA2 pathway, which is important for DNA repair. Results of this research are published online in Genes & Development.

Unraveling the mystery of DNA attacks in cells' powerhouse could pave way for new cancer treatments

April 28, 2017
New research has unravelled the mystery of how mitochondria—the energy generators within cells—can withstand attacks on their DNA from rogue molecules.

New discovery in motor neuron disease and dementia could pave the way to novel treatments

July 17, 2017
New discovery in motor neurone disease and dementia could pave the way to novel treatments

New discovery in understanding chemotherapy resistance could prevent cancer cells fighting back

October 28, 2016
Scientists have made an important breakthrough in understanding why some cancer cells become resistant to chemotherapy.

New research uncovers 'stability protein' for cancer treatment

May 4, 2018
Researchers from the Novo Nordisk Foundation Center for Protein Research at the Faculty of Health and Medical Sciences have characterised a new protein that is important to the genetic stability of cells. It may be significant ...

New study unravels mystery of a DNA repair process

March 14, 2012
(Medical Xpress) -- Scientists at the University of Sussex have uncovered the mechanism of a key process in DNA repair that helps prevent neurodegenerative diseases such as ataxia.

Recommended for you

Importance of cell cycle and cellular senescence in the placenta discovered

October 15, 2018
Working with researchers from Stanford University and St. Anna Children's Cancer Research, researchers from Jürgen Pollheimer's laboratory at the Medical University of Vienna's Department of Obstetrics and Gynecology have ...

Team's study reveals hidden lives of medical biomarkers

October 12, 2018
What do medical biomarkers do on evenings and weekends, when they might be considered off the clock?

Researchers find a 'critical need' for whole genome sequencing of young cancer patients

October 12, 2018
St. Jude Children's Research Hospital has re-defined the gold standard for diagnostic testing of childhood cancer patients in the precision-medicine era and has implemented the testing for new cancer patients. The findings ...

Novel genetic study sheds new light on risk of heart attack

October 12, 2018
Loss of a protein that regulates mitochondrial function can greatly increase the risk of myocardial infarction (heart attack), Vanderbilt scientists reported Oct. 3 in the journal eLife.

Study: DNA websites cast broad net for identifying people

October 11, 2018
About 60 percent of the U.S. population with European heritage may be identifiable from their DNA by searching consumer websites, even if they've never made their own genetic information available, a study estimates.

First two papers based on studies using full set of data in the UK Biobank published

October 11, 2018
Two teams of researchers have independently published papers describing research conducted using the full set of data in the UK Biobank—both in the journal Nature. The first team comprised researchers from the U.K., Australia ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.